A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NSTEMI / non-STEMI

[Related PubMed/MEDLINE]
Total Number of Papers: 107
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NSTEMI  (>> Co-occurring Abbreviation)
Long Form:   non-STEMI
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Acute Myocardial Infarction Outcomes in Systemic Lupus Erythematosus (from the Nationwide Inpatient Sample). OR, SLE, STEMI
2019 Are there gender differences in acute management and secondary prevention of acute coronary syndromes in Barbados? A cohort study. MI, STEMI
2019 Association between time of hospitalization with acute myocardial infarction and in-hospital mortality. AMI, CI, ORs, STEMI
2019 Evaluation of Bleeding Risk in Patients with Acute Myocardial Infarction Undergoing Transradial Percutaneous Coronary Intervention. AMI, MI, PCI, SBP, STEMI, TIMI
2019 Higher in-hospital mortality during weekend admission for acute coronary syndrome: a large-scale cross-sectional Italian study. ACS, OR, STEMI
2019 In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry. DOACs, STEMI
2019 Whole-Body Plethysmography and Blood Gas Analysis in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. AMI, CHD, COPD, PFT, STEMI
2018 Acute Coronary Syndromes in Heart Transplant Recipients (from a National Database Analysis). ACS, CS, STEMI, UAP
2018 Analysis of the Blood Viscosity Behavior in the Sicilian Study on Juvenile Myocardial Infarction. STEMI
10  2018 Association of invasive treatment and lower mortality of patients ≥ 80 years with acute myocardial infarction: a propensity-matched analysis. AMI, STEMI
11  2018 Determinants of Slow Flow in Percutaneous Coronary Intervention to the Culprit Lesion of Non-ST Elevation Myocardial Infarction. IVUS, PCI, STEMI
12  2018 Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry. FI, MI, STEMI, STEMI, STEMI
13  2018 Guideline-adherence regarding critical time intervals in the German Chest Pain Unit registry. ACS, CPUs, PCI, STEMI
14  2018 High-grade atrioventricular block in patients with acute myocardial infarction. Insights from a contemporary multi-center survey. AMI, HAVB, STEMI
15  2018 Long-term follow-up of antithrombotic management patterns in acute coronary syndrome patients. AC, ACS, AMPs, AP, CV, STEMI, UA
16  2018 Predictive Value of Endocan Based on TIMI Risk Score on Major Adverse Cardiovascular Events After Acute Coronary Syndrome. ACS, MACEs, STEMI, TIMI, UA
17  2018 Temporal trends in acute myocardial infarction presentation and association with use of cardioprotective drugs: a nationwide registry-based study. CI, CI 0.78-0.87, MI, OR, STEMI
18  2018 Weekend effect in acute coronary syndrome: A meta-analysis of observational studies. CI, OR, STEMI
19  2017 Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group". STEMI
20  2017 Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. CI, PCI, STEMI
21  2017 Blocked Coronary Artery Due To Coronary Spasm Treated With Stent Insertion: A Sub-Optimal Result? MI
22  2017 Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2. MI, STEMI, TIMI
23  2017 Gender difference in the use of coronary interventions for patients with acute coronary syndrome: Experience from a major metropolitan hospital in Melbourne, Australia. ACS, STEMI, UA
24  2017 Gender differences in the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20 years in Switzerland. AMI, STEMI
25  2017 Left Circumflex Coronary Artery as the Culprit Vessel in ST-Segment-Elevation Myocardial Infarction. LAD, LCX, RCA, STEMI
26  2017 Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study. EMRR, STEMI
27  2017 Relationship between serum 25-hydroxyvitamin D levels and the SYNTAX score in patients with acute coronary syndrome. ACS, CAD, MLR, STEMI, SXscore
28  2017 Relationship of activin A levels with clinical presentation, extent, and severity of coronary artery disease. CAD, STEMI, UA
29  2017 Treatment and outcomes of patients under 40 years of age with acute myocardial infarction in Poland in 2009-2013: an analysis from the PL‑ACS registry. AMI, STEMI
30  2016 Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study. AMI, CI, CR, HR, STEMI
31  2016 Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction. MI, RNA-seq, STEMI
32  2016 Clinical Profile with Angiographic Correlation in Naive Acute Coronary Syndrome. ACS, BMI, STEMI
33  2016 Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort. AMI, PCI, STEMI
34  2016 Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction. HR, MI, PCI, STEMI
35  2016 Plasma EMMPRIN levels in acute myocardial infarction and stable coronary artery disease. AMI, CAD, EMMPRIN, STEMI
36  2016 Pre-hospital management of acute coronary syndrome patients in Belgium and Luxembourg and other Western European countries. FMA, PHC, PHM, STEMI, UA, WEU
37  2016 Recent Trends in Hospitalization for Acute Myocardial Infarction in Beijing: Increasing Overall Burden and a Transition From ST-Segment Elevation to Non-ST-Segment Elevation Myocardial Infarction in a Population-Based Study. AMI, LOS, STEMI
38  2016 Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary. ACS, EMA, STEMI
39  2016 Spontaneous Coronary Artery Dissection: One Disease, Variable Presentations, and Different Management Approaches. IVUS, OCT, PCI, SCAD, STEMI
40  2016 The effect of percutaneous coronary intervention on habitual physical activity in older patients. ACS, PCI, STEMI
41  2016 The meaning of elevated troponin I levels: not always acute coronary syndromes. ACS, CI, STEMI
42  2015 Association between plasma ADAMTS-7 levels and ventricular remodeling in patients with acute myocardial infarction. AMI, BNP, ELISA, LVEDD, LVEF, LVESD, LVMI, ROC, STEMI
43  2015 Clinical application of high-sensitivity cardiac troponin T test in acute myocardial infarction diagnosis. AMI, AUC, cTnI, hs-cTnT, ROC, STEMI
44  2015 Clinical characteristics, management and 1-year outcomes of patients with acute coronary syndrome in Iran: the Iranian Project for Assessment of Coronary Events 2 (IPACE2). ACS, HR-UA, IPACE2, MACCEs, PCI, STEMI
45  2015 Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy). ADAPT-DES, CAD, MLA, STEMI, TCFA, UA, VH
46  2015 Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. ADP-PA
47  2015 Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany. ACS, ASA, STEMI
48  2015 Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction. ACE, AMI, IQR, LVEF, STEMI
49  2015 Incidence and timing of serious arrhythmias after early revascularization in non ST-elevation myocardial infarction. AV, STEMI
50  2015 Percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion: status update 2014. AMI, CABG, PCI, STEMI, TIMI, ULMCA
51  2015 The relationship between fragmented QRS complexes and SYNTAX and Gensini scores in patients with acute coronary syndrome. ACS, CAD, ECG, fQRS, STEMI, USAP
52  2015 Translation of acute coronary syndrome therapies: from evidence to routine clinical practice. ACC, ACS, AHA, IQR, PCTs, STEMI, UA
53  2015 Use of copeptin in emergency patients with cardiac chief complaints. AHF, AMI, CI, ED, HR, NPV, PPV, STEMI
54  2014 Age-dependent improvements in survival after hospitalisation with acute myocardial infarction: an analysis of the Myocardial Ischemia National Audit Project (MINAP). AMI, MINAP, RMAR, RS, STEMI
55  2014 Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry. DES, NRDES, STEMI
56  2014 Correlation between fragmented QRS and the short-term prognosis of patients with acute myocardial infarction. AMI, fQRS, LVSD, PCI, STEMI
57  2014 Impact of hypertension history on short and long-term prognosis in patients with acute myocardial infarction treated with percutaneous angioplasty: comparison between STEMI and NSTEMI. HTN, LVEF, MI, PCI, STEMI
58  2014 Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction. MI, STEMI
59  2014 Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry. ACS, STEMI
60  2014 Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on? AF, NSTE-ACS, STEMI
61  2014 The association of myocardial infarction process of care measures and in-hospital mortality: a report from the NCDR. CMS, STEMI
62  2014 Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003-2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). AMI, NICOR, PPCI, STEMI, TR
63  2013 A rare case of fondaparinux-induced major bleeding in postmenopausal woman prescribed for non-ST segment elevation Ml. STEMI
64  2013 Are there gender differences in coronary artery disease? The Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) Registry. CAD, CI, LMS, NCVD-PCI, OR, PCI, STEMI
65  2013 Comparison of intravascular ultrasound and histological findings in culprit coronary plaques between ST-segment elevation and non-ST-segment elevation myocardial infarction. IVUS, STEMI
66  2013 Correlation between major adverse cardiac events and coronary plaque characteristics. CCTA, MACE, STEMI
67  2013 Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. MACE, re-AMI, STEMI, TIMI
68  2013 The Epidemiology of Acute Coronary Syndrome in Oman: Results from the Oman-RACE study. ACS, ASR, DM, PY, STEMI
69  2013 Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial. CMR, MO, PCI, STEMI, TATORT-NSTEMI
70  2013 TLR4 expression on monocyte subsets in myocardial infarction. CAD, IL-6, MI, Mon1, STEMI, TLR4
71  2013 What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients? ACS, STEMI
72  2012 Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. MI, STEMI
73  2012 Angiographic lesion severity and subsequent myocardial infarction. STEMI
74  2012 Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction. CP, MI, NRMI
75  2012 Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study. HR, IVUS, MACE, STEMI
76  2012 Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study. AMI, STEMI
77  2011 C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study. HR, LAMP II, ROC, STEMI
78  2011 Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry). MACEs, MI, STEMI
79  2011 Electrocardiographic estimates of regional action potential durations and repolarization time subintervals reveal ischemia-induced abnormalities in acute coronary syndrome not evident from global QT. APD, endo, epi, epi, ET, RTs, STEMI
80  2011 Left circumflex occlusion in acute myocardial infarction (from the National Cardiovascular Data Registry). LCX, STEMI
81  2011 Patient-reported symptoms in acute myocardial infarction: differences related to ST-segment elevation: the MONICA/KORA Myocardial Infarction Registry. AMI, CI, MI, OR, STEMI
82  2011 Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: time-dependent comparison with other biomarkers: time-dependent comparison with other biomarkers. CK-MB, H-FABP, non-AMI, STEMI
83  2010 ACS patients in New Zealand experience significant delays to access cardiac investigations and revascularisation treatment especially when admitted to non-interventional centres: results of the second comprehensive national audit of ACS patients. ACS, STEMI, UAP
84  2010 Microvascular retinal changes in patients presenting with acute coronary syndromes. ACS, AVR, CAD, STEMI
85  2010 Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention. LM, MI, PCI, STEMI, TLR
86  2010 Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. ACS, CABG, NZ, PCI, STEMI, UAP
87  2010 Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance. cTnI, DE-CMR, STEMI
88  2009 Cobalt-chrome MULTI-LINK VISION-stent implantation in diabetics and complex lesions: results from the DaVinci-Registry. CABG, Co-Cr, DES, MACE, TVR
89  2009 Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris. CI, PCI, RR, STEMI, UA
90  2009 Drug-eluting stent fracture and acute coronary syndrome. DES, MAUDE, STEMI
91  2009 Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. STEMI
92  2009 Sex differences in mortality following acute coronary syndromes. ACS, CI, OR, STEMI
93  2009 ST deviation pattern in acute myocardial infarction is not related to lesion location. STEMI
94  2009 Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention. ACS, CI, HR, MI, OR, PCI
95  2008 Cardiac troponin I measurement using the ACS:180 to predict four-year cardiac event rate. cTnI, STEMI
96  2008 Fondaparinux sodium: a review of its use in the management of acute coronary syndromes. ACS, STEMI, UFH
97  2008 Spotlight on fondaparinux sodium in acute coronary syndromes. ACS, STEMI
98  2007 Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). PCI, STEMI
99  2007 Myotrophin is a more powerful predictor of major adverse cardiac events following acute coronary syndrome than N-terminal pro-B-type natriuretic peptide. ACS, CI, MACE, MI
100  2007 STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). STEMI